Clinical Trial Update: Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.

View source ↗

Summary

Clinical trial update describing a study on how venetoclax plasma levels relate to toxicity when combined with hypomethylating agents in patients with acute mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dacogen (decitabine)
• VIDAZA (AZACITIDINE)
• Venclexta (venetoclax)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: AML (Acute Myelogenous Leukemia | Status: RECRUITING